30 related articles for article (PubMed ID: 38431093)
1. Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis.
Koh E; Lee EJ; Nam GH; Hong Y; Cho E; Yang Y; Kim IS
Biomaterials; 2017 Mar; 121():121-129. PubMed ID: 28086180
[TBL] [Abstract][Full Text] [Related]
2. Exosomes secreted from human umbilical cord mesenchymal stem cells promote pancreatic ductal adenocarcinoma growth by transferring miR-100-5p.
Ding Y; Mei W; Zheng Z; Cao F; Liang K; Jia Y; Wang Y; Liu D; Li J; Li F
Tissue Cell; 2021 Dec; 73():101623. PubMed ID: 34543801
[TBL] [Abstract][Full Text] [Related]
3. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
5. Smart exosomes enhance PDAC targeted therapy.
Creeden JF; Sevier J; Zhang JT; Lapitsky Y; Brunicardi FC; Jin G; Nemunaitis J; Liu JY; Kalinoski A; Rao D; Liu SH
J Control Release; 2024 Apr; 368():413-429. PubMed ID: 38431093
[TBL] [Abstract][Full Text] [Related]
6. Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma.
Xu B; Chen Y; Peng M; Zheng JH; Zuo C
Int J Cancer; 2023 Jan; 152(2):110-122. PubMed ID: 35765844
[TBL] [Abstract][Full Text] [Related]
7. Camouflage strategies for therapeutic exosomes evasion from phagocytosis.
Parada N; Romero-Trujillo A; Georges N; Alcayaga-Miranda F
J Adv Res; 2021 Jul; 31():61-74. PubMed ID: 34194832
[TBL] [Abstract][Full Text] [Related]
8. Exosomes and the Future of Immunotherapy in Pancreatic Cancer.
Batista IA; Melo SA
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699928
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between Pancreatic Cancer Cells and Cancer-Associated Fibroblasts in the Tumor Microenvironment Mediated by Exosomal MicroRNAs.
Chu X; Yang Y; Tian X
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076911
[TBL] [Abstract][Full Text] [Related]
10. Overcoming immunotherapeutic resistance in PDAC: SIRPα-CD47 blockade.
Alausa A; Lawal KA; Babatunde OA; Obiwulu ENO; Oladokun OC; Fadahunsi OS; Celestine UO; Moses EU; Akaniro IR; Adegbola PI
Pharmacol Res; 2022 Jul; 181():106264. PubMed ID: 35597384
[TBL] [Abstract][Full Text] [Related]
11. Emerging Evidence for the Clinical Relevance of Pancreatic Cancer Exosomes.
Massoumi RL; Hines OJ; Eibl G; King JC
Pancreas; 2019 Jan; 48(1):1-8. PubMed ID: 30531240
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
